Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tau as a drug target in Alzheimer's disease.

× No keyword cloud information.

12 in total

Review 1. Microtubule-associated proteins and the determination of neuronal form.

Authors: A Matus
Journal: J Physiol (Paris) Date: 1990

Review 2. Microtubule-associated proteins (MAPs) in the peripheral nervous system during development and regeneration.

Authors: J Nunez; I Fischer
Journal: J Mol Neurosci Date: 1997-06 Impact factor: 3.444

3. Protein changes in senile dementia.

Authors: K Iqbal; H M Wiśniewski; M L Shelanski; S Brostoff; B H Liwnicz; R D Terry
Journal: Brain Res Date: 1974-09-06 Impact factor: 3.252

4. Tubulin microheterogeneity increases with rat brain maturation.

Authors: I Gozes; U Z Littauer
Journal: Nature Date: 1978-11-23 Impact factor: 49.962

5. Multiple tubulin forms are expressed by a single neurone.

Authors: I Gozes; K J Sweadner
Journal: Nature Date: 1981-12-03 Impact factor: 49.962

6. Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin.

Authors: D W Cleveland; S Y Hwo; M W Kirschner
Journal: J Mol Biol Date: 1977-10-25 Impact factor: 5.469

7. Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer's disease: potential significance for tau protein phosphorylation.

Authors: J G Sheng; R A Jones; X Q Zhou; J M McGinness; L J Van Eldik; R E Mrak; W S Griffin
Journal: Neurochem Int Date: 2001 Nov-Dec Impact factor: 3.921

Review 8. Tau and axonopathy in neurodegenerative disorders.

Authors: Makoto Higuchi; Virginia M Y Lee; John Q Trojanowski
Journal: Neuromolecular Med Date: 2002 Impact factor: 3.843

9. Identification of 3'UTR region implicated in tau mRNA stabilization in neuronal cells.

Authors: S Aronov; R Marx; I Ginzburg
Journal: J Mol Neurosci Date: 1999-04 Impact factor: 3.444

Review 10. Going new places using an old MAP: tau, microtubules and human neurodegenerative disease.

Authors: M L Garcia; D W Cleveland
Journal: Curr Opin Cell Biol Date: 2001-02 Impact factor: 8.382

7 in total

1. Parkinson's and Alzheimer's diseases: protein aggregations and neuroprotection.

Authors: Illana Gozes
Journal: J Mol Neurosci Date: 2004 Impact factor: 3.444

2. Tau Diagnostics and Clinical Studies.

Authors: Illana Gozes; Günter Höglinger; James P Quinn; Nigel M Hooper; Kina Höglund
Journal: J Mol Neurosci Date: 2017-10 Impact factor: 3.444

Review 3. Neuroprotective strategies in Alzheimer's disease.

Authors: Frank M Longo; Stephen M Massa
Journal: NeuroRx Date: 2004-01

4. The Future for Dementia Research: a Perspective from the Journal of Molecular Neuroscience.

Authors: Illana Gozes
Journal: J Mol Neurosci Date: 2016-11 Impact factor: 3.444

5. Increased phosphorylation of tau and synaptic protein loss in the aged transgenic mice expressing familiar Alzheimer's disease-linked presenilin 1 mutation.

Authors: Xifei Yang; Ying Yang; Jianjun Liu; Geng Li; Edward Yang
Journal: Neurochem Res Date: 2011-08-13 Impact factor: 3.996

6. Tau pathology: predictive diagnostics, targeted preventive and personalized medicine and application of advanced research in medical practice.

Authors: Illana Gozes
Journal: EPMA J Date: 2010-06-12 Impact factor: 6.543

Review 7. A Closer Look into the Role of Protein Tau in the Identification of Promising Therapeutic Targets for Alzheimer's Disease.

Authors: Rubayat Islam Khan; Saif Shahriar Rahman Nirzhor; Barnaly Rashid
Journal: Brain Sci Date: 2018-08-26

7 in total